Difference between revisions of "IDH-1"
Jump to navigation
Jump to search
Jensflorian (talk | contribs) (IDH1 mutation specific antibody) |
Jensflorian (talk | contribs) (→Positive staining: pic update) |
||
| Line 5: | Line 5: | ||
==Positive staining== | ==Positive staining== | ||
*Cytoplasmic<ref>{{Cite journal | last1 = Capper | first1 = D. | last2 = Weissert | first2 = S. | last3 = Balss | first3 = J. | last4 = Habel | first4 = A. | last5 = Meyer | first5 = J. | last6 = Jäger | first6 = D. | last7 = Ackermann | first7 = U. | last8 = Tessmer | first8 = C. | last9 = Korshunov | first9 = A. | title = Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. | journal = Brain Pathol | volume = 20 | issue = 1 | pages = 245-54 | month = Jan | year = 2010 | doi = 10.1111/j.1750-3639.2009.00352.x | PMID = 19903171 }}</ref> | *Cytoplasmic<ref>{{Cite journal | last1 = Capper | first1 = D. | last2 = Weissert | first2 = S. | last3 = Balss | first3 = J. | last4 = Habel | first4 = A. | last5 = Meyer | first5 = J. | last6 = Jäger | first6 = D. | last7 = Ackermann | first7 = U. | last8 = Tessmer | first8 = C. | last9 = Korshunov | first9 = A. | title = Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. | journal = Brain Pathol | volume = 20 | issue = 1 | pages = 245-54 | month = Jan | year = 2010 | doi = 10.1111/j.1750-3639.2009.00352.x | PMID = 19903171 }}</ref> | ||
** Does not stain endothelial cells and inflammatory cells. | |||
<gallery> | <gallery> | ||
File:IDH1_GBM_20x.jpg | IDH-1 (R132H) in a secondary glioblastoma | File:IDH1_GBM_20x.jpg | IDH-1 (R132H) in a secondary glioblastoma | ||
File:IDH1R132H oligoastrocytoma.jpg | IDH-1 in a oliogoastrocytoma grade II | |||
File:Neuropathology case IX.jpg | Absence of IDH-1 in a primary glioblastoma | |||
</gallery> | </gallery> | ||
Revision as of 08:10, 6 October 2015
IDH1 staining in oligodendroglioma.
Isocitrate dehydrogenase 1 (R132H), often abbreviated IDH1 or IDH-1 is a mutation-specific antibody detecting the R132H mutation in tumor material.[1]
Positive staining
- Cytoplasmic[2]
- Does not stain endothelial cells and inflammatory cells.
IDH-1 (R132H) in a secondary glioblastoma
IDH-1 in a oliogoastrocytoma grade II
Absence of IDH-1 in a primary glioblastoma
Note:
- The antibody does not detect other rare IDH-1/2 mutations (ie. R132G or R172K).
Normal tissues
- Absent
Tumours
Negative
Negative staining:[5]
- Non-tumorous tissue, endothelial cells.
- Ependymoma
- Pilocytic astrocytoma
- Neuronal tumors
- Sarcoma, carcinoma [6]
See also
References
- ↑ Capper, D.; Zentgraf, H.; Balss, J.; Hartmann, C.; von Deimling, A. (Nov 2009). "Monoclonal antibody specific for IDH1 R132H mutation.". Acta Neuropathol 118 (5): 599-601. doi:10.1007/s00401-009-0595-z. PMID 19798509.
- ↑ Capper, D.; Weissert, S.; Balss, J.; Habel, A.; Meyer, J.; Jäger, D.; Ackermann, U.; Tessmer, C. et al. (Jan 2010). "Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors.". Brain Pathol 20 (1): 245-54. doi:10.1111/j.1750-3639.2009.00352.x. PMID 19903171.
- ↑ Capper, D.; Reuss, D.; Schittenhelm, J.; Hartmann, C.; Bremer, J.; Sahm, F.; Harter, PN.; Jeibmann, A. et al. (Feb 2011). "Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.". Acta Neuropathol 121 (2): 241-52. doi:10.1007/s00401-010-0770-2. PMID 21069360.
- ↑ Andrulis, M.; Capper, D.; Luft, T.; Hartmann, C.; Zentgraf, H.; von Deimling, A. (Aug 2010). "Detection of isocitrate dehydrogenase 1 mutation R132H in myelodysplastic syndrome by mutation-specific antibody and direct sequencing.". Leuk Res 34 (8): 1091-3. doi:10.1016/j.leukres.2010.02.014. PMID 20227112.
- ↑ Capper, D.; Reuss, D.; Schittenhelm, J.; Hartmann, C.; Bremer, J.; Sahm, F.; Harter, PN.; Jeibmann, A. et al. (Feb 2011). "Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.". Acta Neuropathol 121 (2): 241-52. doi:10.1007/s00401-010-0770-2. PMID 21069360.
- ↑ Sahm, F.; Capper, D.; Meyer, J.; Hartmann, C.; Herpel, E.; Andrulis, M.; Mechtersheimer, G.; Petersen, I. et al. (Jun 2011). "Immunohistochemical analysis of 1844 human epithelial and haematopoietic tumours and sarcomas for IDH1R132H mutation.". Histopathology 58 (7): 1167-72. doi:10.1111/j.1365-2559.2011.03823.x. PMID 21707716.